Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C015 - Botulinum Toxin: Video Instruction and Live Panel Discussion

Saturday, February 17; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify nuanced targets for botulinum toxin injection through expert evaluation and analysis.
  • Apply video lessons and pearls to determine optimal treatment sites and doses.
  • Inject safely and manage potential complications.

Description

Master injectors from North America will share video techniques and pearls. Audience members will try and predict injection locations and botulinum toxin doses in this interactive session. Presenters will challenge you with novel approaches which can be used immediately in your practice. Expect to learn several pearls from this expert team.

Disclosures

  • Carruthers, Jean D.A., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Alphaeon – I(Grants/Research Funding); Bonti – C(NC); Kythera – C(H); Kythera Biopharmaceuticals – I(H); Merz Aesthetics – C(H), I(H); Revance Therapeutics, Inc. – I(H);
  • Chilukuri, Suneel, MD: Allergan, Inc – Speaker/Faculty Education(H); BTL Industries – Speaker/Faculty Education(H); Cynosure, Inc – Speaker/Faculty Education(H); Galderma USA – Speaker/Faculty Education(H); PCA SKIN – Speaker/Faculty Education(H); SkinMedica, Inc. – I(Grants/Research Funding); Suneva Medical, Inc. – Speaker/Faculty Education(H); Theravant Corporation – Speaker/Faculty Education(H);
  • Cohen, Joel Lee, MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); LEO Pharma, US – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sciton Inc. – C(H);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – Speaker/Faculty Education(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – SH(ST); Valeant Pharmaceuticals North America LLC – C(H);
  • Maas, Corey, MD: Allergan, Inc – A(Grants/Research Funding);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Alphaeon – I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Genentech, Inc. – SP(H); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Solish, Nowell J., MD: Allergan, Inc – A(H); Allergan, Inc. – SP(H); Galderma USA – SP(H); International hyperhidrosis society – B(H); Revance Therapeutics, Inc. – A(H);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
Schedule
Saturday, February 17
1:00 PM
Dr. Monheit / Shaping the Brow with Neuromodulators
1:15 PM
Dr. Cox / Off Label Use For Neuromodulators
1:30 PM
Dr. Monheit and Dr. Cox / Q&A/Discussion
1:45 PM
Dr. Carruthers / Platysma BoNTA and the Nefertiti Lift
2:00 PM
Dr. Weinkle / Refining the Art of Botox, Thoughts from Florida
2:15 PM
Dr. Carruthers and Dr. Weinkle / Q&A/Discussion
2:30 PM
Dr. Matarasso / San Francisco Treats: Panfacial Botulinum Toxin Pearls
2:45 PM
Dr. Chilukuri / Neuromodulator Finesse from Texas
3:00 PM
Dr. Chilukuri and Dr. Matarasso / Q&A/Discussion
3:15 PM
Dr. Cohen / Treating the Forehead: On Label and Off Label
3:30 PM
Maas / The Future of BoNTA—Reports on a Recent Escalating Dosage Study
3:45 PM
Dr. Cohen and Maas / Q&A/Discussion
Event Details
  • Date
    Saturday, February 17
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 2
  • CME Credits
    3.00
  • Type
    Ticketed
    MOC
    Restricted
Directors/Co-Directors
  • Suneel Chilukuri, MD, FAAD
Speakers
  • Corey Maas, MD
  • Gary D. Monheit, MD, FAAD
  • Jean D.A. Carruthers, MD
  • Joel Lee Cohen, MD, FAAD
  • Nowell J. Solish, MD, FAAD
  • Seth L. Matarasso, MD, FAAD
  • Sue Ellen Cox, MD, FAAD
  • Susan H. Weinkle, MD, FAAD